Expansion of patient groups eligible for Paxlovid treatment for COVID-19 Department of Health - 25 Apr 2024 Expansion of patient groups eligible for Paxlovid treatment for COVID-19 ... More
Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir | Latest news for Doctors ... MIMS - 29 Apr 2024 Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir | Latest news for Doctors ... ... More
Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation Nature.com - 01 Nov 2023 Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation ... More
Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial News-Medical.Net - 08 Apr 2024 Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial ... More
Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir–ritonavir in adult patients with COVID-19: A ... ScienceDirect.com - 23 Apr 2024 Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir–ritonavir in adult patients with COVID-19: A ... ... More
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19 Clinical Trials Arena - 10 Nov 2023 Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19 ... More
COVID-19 treatments extended for groups of patients in NI likely to be at highest risk from COVID-19 infection Belfast News Letter - 25 Apr 2024 COVID-19 treatments extended for groups of patients in NI likely to be at highest risk from COVID-19 infection ... More
The effect of nirmatrelvir-ritonavir on hospital admissions and mortality from COVID-19 IDSA - 21 Dec 2023 The effect of nirmatrelvir-ritonavir on hospital admissions and mortality from COVID-19 ... More
WHO updates guidelines on treatments for COVID-19 World Health Organization (WHO) - 10 Nov 2023 WHO updates guidelines on treatments for COVID-19 ... More
1.4 million more people at risk of severe COVID-19 to have access to antiviral Paxlovid NICE - 11 Jan 2024 1.4 million more people at risk of severe COVID-19 to have access to antiviral Paxlovid ... More
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation Nature.com - 16 Dec 2023 Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation ... More
Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals News-Medical.Net - 08 Jan 2024 Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals ... More
Predictors of nirmatrelvir–ritonavir receipt among COVID-19 patients in a large US health system | Scientific Reports Nature.com - 29 Mar 2024 Predictors of nirmatrelvir–ritonavir receipt among COVID-19 patients in a large US health system | Scientific Reports ... More
One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals News-Medical.Net - 16 Nov 2023 One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals ... More
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a ... Nature.com - 09 Feb 2024 Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a ... ... More
Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity News-Medical.Net - 16 Nov 2023 Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity ... More
Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study | Scientific Reports Nature.com - 11 Nov 2023 Nirmatrelvir/ritonavir and risk of long COVID symptoms: a retrospective cohort study | Scientific Reports ... More
One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID News-Medical.Net - 13 Nov 2023 One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID ... More
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir Nature.com - 11 Sep 2023 Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir ... More